n-methyl-3,4-methylenedioxyamphetamine has been researched along with fluorobenzenes in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (22.22) | 18.2507 |
2000's | 10 (55.56) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fadayel, GM; Schmidt, CJ; Sullivan, CK; Taylor, VL | 1 |
Carr, AA; Dudley, MW; Gittos, MW; Kehne, JH; Moser, P; Palfreyman, MG; Schmidt, CJ; Sorensen, SM | 1 |
Fadayel, GM; Schmidt, CJ; Sullivan, CK | 1 |
Dudley, MW; Kehne, JH; Ketteler, HJ; McCloskey, TC; Schmidt, CJ; Sullivan, CK | 1 |
Hashimoto, K; Higuchi, T; Iyo, M; Minabe, Y; Shirayama, Y; Watanabe, K | 1 |
Bankson, MG; Cunningham, KA | 1 |
Fantegrossi, WE; Godlewski, T; Karabenick, RL; Rice, KC; Stephens, JM; Ullrich, T; Woods, JH | 1 |
Chen, X; Fantegrossi, WE; Karabenick, RL; Kiessel, CL; Leach, PT; Ohizumi, Y; Rice, KC; Ullrich, T; Van Martin, C; Woods, JH | 1 |
Blessing, WW; Nalivaiko, E; Ootsuka, Y | 1 |
Cunningham, KA; Herin, DV; Liu, S; Rice, KC; Ullrich, T | 1 |
Ball, KT; Rebec, GV | 1 |
Fantegrossi, WE; Katz, EB; Reissig, CJ; Rice, KC; Winter, JC; Yarosh, HL | 1 |
Fantegrossi, WE | 1 |
Bauzo, RM; Fantegrossi, WE; Goodman, MM; Howell, LL; Manvich, DM; Morales, JC; Votaw, JR | 1 |
Lanfumey, L; Maldonado, R; Orejarena, MJ; Robledo, P | 1 |
Howell, LL; Kimmel, HL; Murnane, KS; Rice, KC | 1 |
Abi-Dargham, A; Frankle, WG; Girgis, RR; Hart, CL; Kegeles, LS; Laruelle, M; Slifstein, M; Talbot, PS; Urban, NB; Xu, X | 1 |
Belkoff, AR; Berro, LF; Curry, DW; Howell, LL; Rice, KC; Sulima, A | 1 |
18 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and fluorobenzenes
Article | Year |
---|---|
5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Dialysis; Dopamine; Fluorobenzenes; Haloperidol; Homovanillic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin Antagonists | 1992 |
Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function.
Topics: Animals; Basal Ganglia Diseases; Behavior, Animal; Dopamine; Electrophysiology; Fluorobenzenes; Indoles; Male; Mice; Microdialysis; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Piperidines; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists | 1993 |
Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Fluorobenzenes; Homovanillic Acid; Kinetics; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Tetrodotoxin | 1994 |
Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain Chemistry; Clozapine; Dopamine Antagonists; Fluorobenzenes; Male; Methiothepin; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Presynaptic Terminals; Rats; Receptors, Neurotransmitter; Ritanserin; Serotonin; Serotonin Agents; Serotonin Antagonists; Stimulation, Chemical | 1996 |
3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation.
Topics: Animals; Benzazepines; Brain Chemistry; Dizocilpine Maleate; DNA-Binding Proteins; Dopamine Antagonists; Early Growth Response Protein 1; Excitatory Amino Acid Antagonists; Fluorobenzenes; Hallucinogens; Immediate-Early Proteins; Immunohistochemistry; In Situ Hybridization; Male; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Phenols; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Transcription Factors | 2000 |
Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Fluorobenzenes; Hallucinogens; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Oxadiazoles; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Antagonists | 2002 |
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Topics: Animals; Body Temperature; Cold Temperature; Crowding; Dose-Response Relationship, Drug; Fluorobenzenes; Fluoxetine; Hallucinogens; Ketanserin; Lethal Dose 50; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Platelet Aggregation Inhibitors; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Isolation; Stereoisomerism; Telemetry | 2003 |
Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
Topics: Adrenergic alpha-Antagonists; Animals; Aporphines; Behavior, Animal; Crowding; Dose-Response Relationship, Drug; Fever; Fluorobenzenes; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Prazosin; Serotonin Agents; Serotonin Antagonists; Stereoisomerism | 2004 |
Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine.
Topics: Animals; Clozapine; Ear, External; Fluorobenzenes; Injections, Intravenous; N-Methyl-3,4-methylenedioxyamphetamine; Phenols; Rabbits; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Skin; Spine; Tail; Ultrasonography, Doppler, Pulsed; Vasoconstriction; Vasomotor System | 2004 |
Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.
Topics: Animals; Dose-Response Relationship, Drug; Drug Antagonism; Drug Therapy, Combination; Fever; Fluorobenzenes; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Time Factors | 2005 |
Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
Topics: Amphetamine-Related Disorders; Animals; Corpus Striatum; Dopamine; Electroencephalography; Fluorobenzenes; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Phenols; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin Antagonists; Serotonin Receptor Agonists | 2005 |
Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
Topics: Animals; Data Interpretation, Statistical; Discrimination Learning; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Lysergic Acid Diethylamide; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Piperidines; Psilocybin; Pyridines; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Tryptamines | 2008 |
In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.
Topics: Animals; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Fluorobenzenes; Macaca mulatta; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Positron-Emission Tomography; Reinforcement, Psychology; Self Administration; Serotonin Antagonists; Stereoisomerism | 2008 |
Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Electrochemical Techniques; Female; Fluorine Radioisotopes; Fluorobenzenes; Hallucinogens; Macaca mulatta; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nortropanes; Piperidines; Positron-Emission Tomography; Reinforcement Schedule; Saimiri; Serotonin Antagonists; Tropanes | 2009 |
Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour.
Topics: Animals; Behavior, Addictive; Cues; Dopamine; Dose-Response Relationship, Drug; Extinction, Psychological; Female; Fluorobenzenes; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Nucleus Accumbens; Phenols; Prefrontal Cortex; Receptor, Serotonin, 5-HT2A; Reinforcement, Psychology; Self Administration; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2011 |
The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.
Topics: Animals; Female; Fluorobenzenes; Fluoxetine; Hallucinogens; Macaca mulatta; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Stereoisomerism; Time Factors | 2012 |
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
Topics: Adult; Amphetamine-Related Disorders; Benzylamines; Brain Mapping; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neocortex; Piperidines; Positron-Emission Tomography; Protein Binding; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Young Adult | 2012 |
Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA).
Topics: Animals; Behavior, Animal; Fluorobenzenes; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Serotonin Agents; Serotonin Antagonists; Social Behavior | 2019 |